Literature DB >> 10651843

Evaluation of CD14 in host defence.

P Antal-Szalmás1.   

Abstract

An extensive search for the cell membrane targets for lipopolysaccharide (LPS), the major causative agent of Gram-negative septic shock, resulted in the identification of CD14 as the major endotoxin 'receptor'. Besides recognition of LPS, several new aspects of its biological functions have been described recently. In this review the different CD14 forms, their most important biological and biochemical features, signalling properties, cellular and subcellular distribution and association with different diseases are discussed in detail, showing that these molecules posses several unique biological functions and further proving their central role in innate immunity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10651843     DOI: 10.1046/j.1365-2362.2000.00610.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  33 in total

1.  Regulation of endotoxin-induced proinflammatory activation in human coronary artery cells: expression of functional membrane-bound CD14 by human coronary artery smooth muscle cells.

Authors:  Lynn L Stoll; Gerene M Denning; Wei-Gen Li; James B Rice; Allan L Harrelson; Sara A Romig; Skuli T Gunnlaugsson; Francis J Miller; Neal L Weintraub
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

2.  Exogenous heat shock protein HSP70 suppresses bacterial pathogen-induced activation of human neutrophils.

Authors:  M M Yurinskaya; M B Evgen'ev; O Yu Antonova; M G Vinokurov
Journal:  Dokl Biochem Biophys       Date:  2010-12-24       Impact factor: 0.788

3.  Primary role of interleukin-1 alpha and interleukin-1 beta in lipopolysaccharide-induced hypoglycemia in mice.

Authors:  Senri Oguri; Katsutoshi Motegi; Yoichiro Iwakura; Yasuo Endo
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

4.  Childhood nephrotic syndrome in relapse is associated with down-regulation of monocyte CD14 expression and lipopolysaccharide-induced tumour necrosis factor-alpha production.

Authors:  S P Chen; W Cheung; C K Heng; S C Jordan; H K Yap
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

Review 5.  Soluble CD14: role in atopic disease and recurrent infections, including otitis media.

Authors:  Karin C Lødrup Carlsen; Berit Granum
Journal:  Curr Allergy Asthma Rep       Date:  2007-11       Impact factor: 4.806

Review 6.  CD14 and toll-like receptor 4: a link between infection and acute coronary events?

Authors:  R Arroyo-Espliguero; P Avanzas; S Jeffery; J C Kaski
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

7.  Surfactant protein D is expressed and modulates inflammatory responses in human coronary artery smooth muscle cells.

Authors:  Gary D Snyder; Rebecca E Oberley-Deegan; Kelli L Goss; Sara A Romig-Martin; Lynn L Stoll; Jeanne M Snyder; Neal L Weintraub
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-03-21       Impact factor: 4.733

8.  Membrane-anchored CD14 is important for induction of interleukin-8 by lipopolysaccharide and peptidoglycan in uroepithelial cells.

Authors:  Toshiaki Shimizu; Shin-ichi Yokota; Satoshi Takahashi; Yasuharu Kunishima; Koh Takeyama; Naoya Masumori; Atsushi Takahashi; Masanori Matsukawa; Naoki Itoh; Taiji Tsukamoto; Nobuhiro Fujii
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

9.  CD14 upregulation as a distinct feature of non-alcoholic fatty liver disease after pancreatoduodenectomy.

Authors:  Daisuke Satoh; Takahito Yagi; Takeshi Nagasaka; Susumu Shinoura; Yuzo Umeda; Ryuichi Yoshida; Masashi Utsumi; Takehiro Tanaka; Hiroshi Sadamori; Toshiyoshi Fujiwara
Journal:  World J Hepatol       Date:  2013-04-27

10.  CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance.

Authors:  Bikash Sahay; Rebeca L Patsey; Christian H Eggers; Juan C Salazar; Justin D Radolf; Timothy J Sellati
Journal:  PLoS Pathog       Date:  2009-12-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.